Skip to content
OpenCapital
Get started

Natural Resource Partners NRP Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Grants In Period Fair Value

Other financials

Income statement

See full
Revenue$51.3M-21.8%
Gross profit$44.5M-25.7%
Operating income$20.6M-52.0%
Net income$19.6M-51.3%
EPS (diluted)$1.44-51.5%

Balance sheet

See full
Cash & equivalents$31.5M+2.0%
Total debt$60.3M-56.5%
Total assets$771.7M+3.1%

Cash flow

See full
Operating cash flow$33.0M-4.1%
CapEx-—
Free cash flow$41.5M-37.4%

Valuation

See full
Market cap$1.33B+6.0%
Enterprise value$1.35B-0.3%
P/E11.5×+4.0×
P/S6.1×+1.8×

Profitability

See full
Gross margin90.2%—
Operating margin84.5%—
Net margin76.9%-18.4pp
FCF margin100.2%-15.3pp

Returns & leverage

See full
Current ratio2.1×-0.4×

Where this comes from

Reported directly by Natural Resource Partners in its filing.

Tagged under the XBRL concept nrp:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue.

The official record: Natural Resource Partners’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Natural Resource Partners's sharebased compensation arrangement by sharebased payment award equity instruments other than options grants in period fair value.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Natural Resource Partners's sharebased compensation arrangement by sharebased payment award equity instruments other than options grants in period fair value?
Natural Resource Partners (NRP) reported sharebased compensation arrangement by sharebased payment award equity instruments other than options grants in period fair value of $8.6M in Q1 2026.
How has Natural Resource Partners's sharebased compensation arrangement by sharebased payment award equity instruments other than options grants in period fair value changed year-over-year?
Natural Resource Partners's sharebased compensation arrangement by sharebased payment award equity instruments other than options grants in period fair value increased by 26.5% year-over-year, from $6.8M to $8.6M.